Medicine is full of names that seem designed to mislead. A blood test labeled “anticoagulant” that actually signals a dangerous tendency to form clots. A disease called “connective tissue disease” whose defining features often have little to do with connective tissue. A form of diarrhea described as “paradoxical” because it emerges from severe constipation. A team of clinicians and researchers from the University Hospital Centre of Bordeaux, writing in BMC Medicine, argues that these contradictory terms—what they call “antinomic” medical terms—represent far more than linguistic curiosities. In their view, they are active obstacles to sound clinical reasoning, efficient medical education, and honest communication with patients.
The concept at the heart of the paper is deceptively simple. An antinomic medical term is one whose literal meaning or surface logic directly contradicts the true pathophysiology or clinical behavior of the condition it names. The authors, led by Etienne Rivière of the Internal Medicine and Infectious Diseases unit at Haut-Lévêque Hospital, catalog a series of such paradoxes and explore why they persist, why they matter, and what could be done about them. Their argument is not merely semantic. They contend that misleading nomenclature imposes a real cognitive load on trainees and practicing physicians alike, forcing the brain to memorize exceptions rather than understand mechanisms, at a time when medical knowledge is already expanding at an overwhelming pace.
The flagship example is the lupus anticoagulant, a name that manages to be wrong twice over. First, the test detects antibodies that are strongly associated with thrombosis, not bleeding; the “anticoagulant” label arises only because the antibodies interfere with clotting tests in the laboratory, prolonging the activated partial thromboplastin time, or aPTT, in a test tube. In the body, the opposite happens: patients carrying these antibodies face an elevated risk of venous and arterial clots. Second, despite the name, many people who test positive have no connection whatsoever to systemic lupus erythematosus. The result is a term that can confuse students preparing for exams and, more worryingly, clinicians making rapid decisions about thrombosis workups, where misreading the meaning of a prolonged aPTT in the presence of these antibodies can lead to inappropriate management.
The authors extend the analysis to the rheumatology clinic. So-called connective tissue diseases, a category that includes systemic lupus erythematosus and related systemic autoimmune conditions, are named for the tissue type once thought to be their unifying pathological substrate. Yet the clinical manifestations of these diseases—rashes, kidney inflammation, joint disease, blood count abnormalities—are driven by immune dysregulation that is not confined to connective tissue, and histological findings frequently fail to match the label. Similarly, lupus pernio, a chronic skin manifestation associated with sarcoidosis, has nothing to do with lupus erythematosus; the name borrows the Latin word for wolf because of the violaceous, wolf-like appearance of the lesions, a historical accident that continues to send learners down the wrong diagnostic path.
Gastroenterology supplies one of the most vivid examples: paradoxical diarrhea, also described in the literature as fecal impaction seepage. In elderly, immobile, or constipated patients, a hard mass of stool obstructs the rectum, and only liquid stool can leak around the blockage, producing what looks like diarrhea. The intuitive response—give an antidiarrheal agent—would be exactly wrong, potentially worsening the impaction and its complications. The correct treatment is disimpaction. The authors argue that the term itself, while memorable, encodes the paradox rather than resolving it, and that a name built on the underlying mechanism, such as overflow diarrhea secondary to fecal impaction, would teach the pathophysiology instead of merely flagging the surprise.
The paper also ventures into cardiology and infectious disease, where naming problems take subtler forms. Heart failure with preserved ejection fraction, or HFpEF, is defined partly by a preserved pumping measurement, yet the symptomatic reality for patients is diastolic dysfunction and congestion; the authors discuss how the framing around ejection fraction can obscure the hemodynamic mechanisms that actually produce breathlessness and fluid retention. In the aftermath of infections, a proliferating zoo of labels—post-acute infection syndromes, post-treatment Lyme disease syndrome, post-infectious chronic syndromes—describes overlapping clinical realities with inconsistent terminology, a fragmentation the authors see as an obstacle both to research and to patients seeking recognition of their persistent symptoms. They also cite heparin-induced thrombocytopenia, a condition in which the drop in platelet count is accompanied, paradoxically, by an increased risk of thrombosis driven by antibodies against platelet factor 4, so that the most feared complication of a platelet-lowering drug is clotting.
Why do such terms survive? The authors point to the deep historical layers of medical language. Many names were coined before the mechanisms were understood, when a visible feature, a laboratory artifact, or a superficial resemblance seemed like the most salient characteristic. Once embedded in textbooks, examination syllabi, billing codes, and decades of literature, a term acquires inertia that is difficult to overcome. Renaming is costly: it disrupts literature searches, breaks continuity with older studies, and requires international consensus in fields where even the definitions of the diseases themselves are contested. The result is a kind of linguistic path dependence, in which each generation of students must learn not only the biology but also the archaeology of the words.
The cost of this inertia, the authors argue, is measured in cognitive overload. Medical education has long been criticized for privileging encyclopedic memorization over mechanistic understanding, and antinomic terms are a concentrated expression of that problem. A student who learns that the lupus anticoagulant causes clots despite its name has memorized a fact; a student who learns why the name exists—because of an in vitro artifact in the aPTT assay—has acquired a transferable insight into laboratory medicine and antibody biology. The authors advocate a pedagogical shift away from rote learning of archaic labels and toward teaching the underlying mechanisms first, with the historical names presented explicitly as fossils of earlier misunderstanding rather than as neutral descriptors.
Beyond the classroom, the authors emphasize the consequences for patients. Terms like lupus anticoagulant or paradoxical diarrhea are not merely confusing to laypeople; they can be actively frightening or misleading when a patient reads them in a laboratory report or discharge summary. A person told they have an “anticoagulant” in their blood may reasonably wonder whether they are at risk of bleeding, when the actual clinical concern is thrombosis. The authors call for a global, cross-disciplinary effort to simplify medical language, involving clinicians, educators, linguists, and patient representatives, with the goal of fostering clinical competence and genuine comprehension rather than the accumulation of opaque vocabulary. They propose specific improvements to current nomenclature, suggesting that the most misleading terms be critically re-examined and, where feasible, renamed in ways that reflect mechanism rather than historical accident.
The paper, published as an open-access debate article, is unlikely to settle the question on its own—renaming entrenched medical terms is a slow, collective enterprise—but it crystallizes a problem that many educators recognize and rarely name so directly. In an era when artificial intelligence tools can retrieve facts instantly, the authors suggest, the value of medical education lies increasingly in deep mechanistic reasoning, and language that contradicts mechanism is a tax on that reasoning. Whether the community chooses to reform its most paradoxical terms or simply to teach them more honestly, the underlying message stands: in medicine, the name of a disease should illuminate the disease, not conceal it, and every term that belies the biology it describes is a small, persistent obstacle between knowledge and understanding.
Subject of Research: Misleading antinomic terminology in medical nomenclature and its impact on clinical reasoning and medical education
Article Title: Medical antinomy: when the name belies the disease
Article References: Rivière, E., Mathé, A., Rivière, P., Bonnet, G., James, C., & Guy, A. (2026). Medical antinomy: when the name belies the disease. BMC Medicine. https://doi.org/10.1186/s12916-026-05220-0
Image Credits: AI Generated
DOI: 10.1186/s12916-026-05220-0
Keywords: medical education, nomenclature, lupus anticoagulant, connective tissue diseases, paradoxical diarrhea, heparin-induced thrombocytopenia, post-acute infection syndromes, clinical reasoning, cognitive overload, systemic lupus erythematosus, BMC Medicine, medical language
News Source: Ophelia Keating. (October 9, 2026). When Medical Names Lie: The Paradoxical Terms That Trip Up Doctors and Patients. Scienmag.
